Studies show that the obesity and diabetes medication also reduces heart attacks, cancer risk, migraines, and memory loss. How is that even possible? And at what point should we all be on it?
GLP-1s—technically known as glucagon like peptide 1 receptor agonists—seem to curb alcohol, cocaine, and tobacco use among addicts. They prevent strokes, heart attacks, chronic kidney disease, sleep apnea, and Parkinson’s disease. They’re associated with a lower risk of several cancers, including pancreatic cancer and multiple myeloma. Arthritic patients on the drugs experienced relief from knee pain that was “on par with opioid drugs.” A small study found that they reduce migraine headaches by 50 percent. And emerging research suggests they might even slow the rate of memory loss among people diagnosed with Alzheimer’s.
